Search ( Ctrl + / )
Neurocrine Biosciences, Inc.
NBIXNASDAQ
NBIXNASDAQ
NBIXNASDAQ
| Published Date | Price Target | Price When Posted | Analyst Company | Analyst Name | Upside/Downside |
|---|---|---|---|---|---|
| July 31, 2025 | 175.00 | 131.95 | Guggenheim | 32.62% | |
| April 28, 2025 | 158.00 | 106.46 | Canaccord Genuity | 48.41% | |
| March 7, 2025 | 150.00 | 113.04 | Morgan Stanley | 32.70% | |
| January 8, 2025 | 162.00 | 137.55 | UBS | Ashwani Verma | 17.78% |
| October 22, 2024 | 192.00 | 116.57 | Oppenheimer | Jay Olson | 64.71% |
| October 10, 2024 | 155.00 | 111.62 | Raymond James | Danielle Brill | 38.86% |
| September 13, 2024 | 128.00 | 122.29 | BMO Capital | Evan David Seigerman | 4.67% |
| September 9, 2024 | 160.00 | 120.17 | Barclays | Carter Gould | 33.14% |
| August 29, 2024 | 136.00 | 123.76 | RBC Capital | Brian Abrahams | 9.89% |
| July 12, 2024 | 170.00 | 146.50 | Morgan Stanley | Jeffrey Hung | 16.04% |
| June 6, 2024 | 141.00 | 133.69 | RBC Capital | Brian Abrahams | 5.47% |
| May 28, 2024 | 193.00 | 139.40 | UBS | Ashwani Verma | 38.45% |
| May 13, 2024 | 175.00 | 136.15 | Evercore ISI | Cory Kasimov | 28.53% |
| May 2, 2024 | 164.00 | 143.03 | Canaccord Genuity | Sumant Kulkarni | 14.66% |
| May 2, 2024 | 160.00 | 143.03 | H.C. Wainwright | Andrew Fein | 11.86% |
| April 23, 2024 | 170.00 | 139.35 | Wells Fargo | Mohit Bansal | 22.00% |
| February 3, 2023 | 130.00 | 108.00 | Morgan Stanley | 20.37% | |
| November 2, 2022 | 150.00 | 119.36 | Robert W. Baird | Brian Skorney | 25.67% |
| November 2, 2022 | 115.00 | 119.36 | SVB Securities | Marc Goodman | -3.65% |
| November 2, 2022 | 103.00 | 119.36 | Piper Sandler | David Amsellem | -13.71% |
| November 2, 2022 | 140.00 | 119.36 | H.C. Wainwright | Andrew Fein | 17.29% |
| February 14, 2022 | 140.00 | 86.52 | H.C. Wainwright | Andrew Fein | 61.81% |
| February 11, 2022 | 125.00 | 85.53 | Raymond James | Danielle Brill | 46.15% |
| February 11, 2022 | 117.00 | 85.53 | Robert W. Baird | Brian Skorney | 36.79% |
| February 11, 2022 | 100.00 | 85.53 | Leerink Partners | Marc Goodman | 16.92% |
| February 11, 2022 | 136.00 | 85.53 | Stifel Nicolaus | Paul Matteis | 59.01% |
| January 26, 2022 | 127.00 | 75.51 | Bank of America Securities | Tazeen Ahmad | 68.19% |
| January 20, 2022 | 100.00 | 72.80 | Barclays | Carter Gould | 37.36% |
| December 8, 2021 | 129.00 | 84.26 | Citigroup | Neena Bitritto-Garg | 53.10% |
| November 2, 2021 | 123.00 | 95.58 | Cantor Fitzgerald | Charles Duncan | 28.69% |
| November 2, 2021 | 130.00 | 95.58 | Evercore ISI | Joshua Schimmer | 36.01% |
| August 6, 2021 | 108.00 | 89.57 | Canaccord Genuity | Sumant Kulkarni | 20.58% |
| August 4, 2021 | 112.00 | 93.20 | Wedbush | Laura Chico | 20.17% |
| Published Date | Price Target | Price When Posted | Analyst Company | Analyst Name | Upside/Downside |
|---|---|---|---|---|---|
| July 31, 2025 | 175.00 | 131.95 | Guggenheim | 32.62% | |
| April 28, 2025 | 158.00 | 106.46 | Canaccord Genuity | 48.41% | |
| March 7, 2025 | 150.00 | 113.04 | Morgan Stanley | 32.70% | |
| January 8, 2025 | 162.00 | 137.55 | UBS | Ashwani Verma | 17.78% |
| October 22, 2024 | 192.00 | 116.57 | Oppenheimer | Jay Olson | 64.71% |
| October 10, 2024 | 155.00 | 111.62 | Raymond James | Danielle Brill | 38.86% |
| September 13, 2024 | 128.00 | 122.29 | BMO Capital | Evan David Seigerman | 4.67% |
| September 9, 2024 | 160.00 | 120.17 | Barclays | Carter Gould | 33.14% |
| August 29, 2024 | 136.00 | 123.76 | RBC Capital | Brian Abrahams | 9.89% |
| July 12, 2024 | 170.00 | 146.50 | Morgan Stanley | Jeffrey Hung | 16.04% |
| June 6, 2024 | 141.00 | 133.69 | RBC Capital | Brian Abrahams | 5.47% |
| May 28, 2024 | 193.00 | 139.40 | UBS | Ashwani Verma | 38.45% |
| May 13, 2024 | 175.00 | 136.15 | Evercore ISI | Cory Kasimov | 28.53% |
| May 2, 2024 | 164.00 | 143.03 | Canaccord Genuity | Sumant Kulkarni | 14.66% |
| May 2, 2024 | 160.00 | 143.03 | H.C. Wainwright | Andrew Fein | 11.86% |
| April 23, 2024 | 170.00 | 139.35 | Wells Fargo | Mohit Bansal | 22.00% |
| February 3, 2023 | 130.00 | 108.00 | Morgan Stanley | 20.37% | |
| November 2, 2022 | 150.00 | 119.36 | Robert W. Baird | Brian Skorney | 25.67% |
| November 2, 2022 | 115.00 | 119.36 | SVB Securities | Marc Goodman | -3.65% |
| November 2, 2022 | 103.00 | 119.36 | Piper Sandler | David Amsellem | -13.71% |
| November 2, 2022 | 140.00 | 119.36 | H.C. Wainwright | Andrew Fein | 17.29% |
| February 14, 2022 | 140.00 | 86.52 | H.C. Wainwright | Andrew Fein | 61.81% |
| February 11, 2022 | 125.00 | 85.53 | Raymond James | Danielle Brill | 46.15% |
| February 11, 2022 | 117.00 | 85.53 | Robert W. Baird | Brian Skorney | 36.79% |
| February 11, 2022 | 100.00 | 85.53 | Leerink Partners | Marc Goodman | 16.92% |
| February 11, 2022 | 136.00 | 85.53 | Stifel Nicolaus | Paul Matteis | 59.01% |
| January 26, 2022 | 127.00 | 75.51 | Bank of America Securities | Tazeen Ahmad | 68.19% |
| January 20, 2022 | 100.00 | 72.80 | Barclays | Carter Gould | 37.36% |
| December 8, 2021 | 129.00 | 84.26 | Citigroup | Neena Bitritto-Garg | 53.10% |
| November 2, 2021 | 123.00 | 95.58 | Cantor Fitzgerald | Charles Duncan | 28.69% |
| November 2, 2021 | 130.00 | 95.58 | Evercore ISI | Joshua Schimmer | 36.01% |
| August 6, 2021 | 108.00 | 89.57 | Canaccord Genuity | Sumant Kulkarni | 20.58% |
| August 4, 2021 | 112.00 | 93.20 | Wedbush | Laura Chico | 20.17% |